Special Physical Exercises as a Therapeutic Intervention for Inflammatory Bowel Disease

Launched by TEL-AVIV SOURASKY MEDICAL CENTER · Mar 8, 2020

Keywords

ClinConnect Summary

This clinical trial is exploring the effects of special physical exercises on individuals with Inflammatory Bowel Disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. The researchers believe that being physically active can help improve various aspects of health, such as overall well-being, sleep quality, and stress levels for patients living with these conditions.

To participate in this trial, you need to be between 18 and 60 years old and currently stable in your condition while on a consistent medication plan. You must also have had specific symptoms that meet the study's criteria. Participants will be required to commit to at least 15 minutes of exercise six times a week. If you join, you can expect to engage in a structured exercise program, and the trial aims to see how this impacts your health and daily life. It's important to know that certain health conditions or situations, like pregnancy or serious infections, may prevent you from joining the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. 18 \< age \< 60
• • 2. Clinically stable patients, constant medicinal regimen throughout the study period. Refractory to mesalamine at least 6 weeks, or steroids at least 2 week, or immunomodulator at least 12 weeks or biologics at least 12 weeks therapy, medical cannabis at least 2 weeks before the study.
• • 3. CD patients will be included if their symptoms score 5≤ between ≤15 on the Harvey-Bradshaw index (HBI) score
• • 4. UC patients will be included if their symptoms score 3≤between≤9 on the Simple Clinical Colitis Activity Index (SCCAI)
• Exclusion Criteria:
• • 1. Inability to commit for performing at least 15 minutes of exercise, 6 times a week
• • 2. Lack of availability or capability to use a computer/ internet.
• • 3. Any proven current infection such as Clostridium difficile infection, positive stool culture, or parasites.
• • 4. Inability to sign informed consent and complete study protocol
• • 5. Pregnancy
• • 6. Subjects with chronic conditions such as cancer, organ transplant subjects, advanced kidney or liver disease, systemic inflammatory conditions other than IBD.
• • 7. Patients with ileostomy, pouch or short bowel